Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: Preclinical studies

Clinical Cancer Research

Volumn 4, Issue 2, 1998, Pages 445-453

  Mohammad, Ramzi M ^a   Katato, Khalil ^a   Almatchy, Victor P ^a   Wall, Nathan ^a   Liu, Kan Zhi ^b   Schultz, Christian P ^b   Mantsch, Henry H ^b   Varterasian, Mary ^a   Al Katib, Ayad M ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; BRYOSTATIN 1; CLADRIBINE; MEMBRANE LIPID;

ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL KILLING; CHRONIC LYMPHATIC LEUKEMIA; DNA CONTENT; FOURIER TRANSFORMATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; TUMOR GROWTH;

ACID PHOSPHATASE; AGED; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL DIVISION; CLADRIBINE; DNA, NEOPLASM; DRUG ADMINISTRATION SCHEDULE; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LACTONES; LEUKEMIA, B-CELL, CHRONIC; LEUKEMIA, HAIRY CELL; LIPID METABOLISM; MACROLIDES; MALE; MICE; MICE, SCID; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0031915022     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Armitage, J. O., Berg, A. R., and Purtilo, D. T. Adult non-Hodgkin's lymphoma. In: R. L. Bick, J. M. Bennett, R. K. Brynes, M. J. Cline, L. Kass, G. Mutano, S. B. Shohet, and P. C. J. Ward (eds.), Hematology Clinical and Laboratory Practice, Vol. 2, pp. 875-893. St. Louis: C. V. Mosby, Inc., 1993.
2. Saven, A., Carrera, C. J., Carson, D. A., Beutler, E., and Piro, L. D. 2-Chlorodeoxyadenosine treatment of refractory chronic lymphocytic leukemia. Leuk. Lymph., 5: 133-138, 1991.
3. Drexler, H. G., Gignac, S. M., Jones, R. A., Scott, C. S., Pettit, G. R., and Hoffbrand, A. V. Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells. Blood, 74: 1747-1757, 1989.
4. Pettit, G. R., Herald, C. L., Doubek, D. L., Herald, D. L., Arnold, E., and Clardy, J. Isolation and structure of bryostatin 1. J. Am. Chem. Soc., 104: 6846-6848, 1982.
5. Al-Katib, A., Mohammad, R. M., Dan, M., Hussein, M. E., Akhtar, A., Pettit, G. R., and Sensenbrenner, L. L. Bryostatin 1-induced hairy cell feature on chronic lymphocytic leukemia cells in vitro. Exp. Hematol, 21: 61-65, 1993.
6. Taillandier, E., and Liquier, F. Infrared spectroscopy of DNA. Methods Enzymol., 211: 307-311, 1992.
7. Mantsch, H. H., and Jackson, M. Molecular spectroscopy in biodiagnostics. J. Mol. Struct., 347: 187-192, 1995.
8. Jackson, M., and Mantsch, H. H. Biomedical infrared spectroscopy. In: H. H. Mantsch and D. Chapman (eds.), Infrared Spectroscopy of Biomolecules, p. 311, Wiley-Liss, Inc., 1996.
9. Schultz, C. P., Liu, K-Z., Johnson, J. B., and Mantsch, H. H. Study of chronic lymphocytic leukemia cells by FT-IR spectroscopy and cluster analysis. Leuk. Res., 20: 649-655, 1996.
10. Liu, K. Z., Schultz, C. P., Johnston, J. B., and Mantsch, H. H. Comparison of infrared spectra of CLL cells with their ex vivo sensitivity (MTT assay) to chlorambucil and cladribine. Leuk. Res., in press, 1998.
11. Mohammad, R. M., Mohamed, A. N., Hamdan, M. Y., Vo, T., Chen, B., Katato, K., Abubakr, Y. A., Dugan, M. C., and Al-Katib, A. Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model. Leukemia (Baltimore), 10: 130-137, 1996.
12. Mohammad, R. M., Al-Katib, A., Pettit, G. R., and Sensenbrenner, L. L. Successful treatment of human Waldenstrom's macroglobulinemia with combination biological and chemotherapy agents. Cancer Res., 54: 165-168, 1994.
13. Hayhoe, F. G., and Flemans, F. J. Color Atlas of Hematological Cytology, 3rd ed. St. Louis: Mosby-Year Book, Inc., 1992.
14. Surewicz, W. K., and Mantsch, H. H. New insight into protein secondary structure from resolution enhanced infrared spectra. Biochim. Biophys. Acta, 952: 115-130, 1988.
15. Philpott, N. J., Turner, A. J. C., Scopes, J., Westby, M., Marsh, J. C. W., Gordon-Smith, E. C., Dalgleish, A. G., and Gibson, F. M. The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood, 87: 2244-2251, 1996.
16. Traweek, S. T., Sheibani, K., Winberg, C. D., Mena, R. R., Wu, A. M., and Rappaport, H. Monocytoid B cell lymphoma: its evaluation and relationship to other low-grade B-cell neoplasms. Blood, 73: 573-578, 1989.
17. Yam, L., Li, C., and Lam, K. Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis. N. Engl. J. Med., 284: 357-360, 1971.
18. Schwarting, R., Stein, H., and Wang, C. Y. The monoclonal antibodies S-HCL1 (Leu14) and S-HCL3 (leuM5) allow the diagnosis of hairy cell leukemia. Blood, 65: 974-983, 1985.
19. Burke, J. S., and Sheibani, K. Hairy cells and monocytoid B lymphocytes: are they related? Leukemia (Baltimore), 1: 298-300, 1987.
20. Mohammad, R. M., Al-Katib, A., Pettit, G. R., and Sensenbrenner, L. L. Differential effects of bryostatin 1 on human non-Hodgkin's B-lymphoma cell lines. Leuk. Res., 17: 1-8, 1993.
21. Nosanchuk, J. S. Hairy-cell leukemia. In: R. L. Bick, J. M. Bennett, R. K. Brynes, M. J. Cline, L. Kass, G, Mutano, S. B. Shohet, and P. C. J. Ward (eds.), Hematology Clinical and Laboratory Practice, Vol. 1, pp. 833-840. St. Louis: C. V. Mosby, Inc., 1993.
22. Anderson, K. C., Boyd, A. W., Fisher, D. C., Leslie, D., Schlossman, S. F., and Nadler, L. M. Hairy cell leukemia: a tumor of pre-plasma cells. Blood, 65: 620-629, 1985.
23. Korsmeyer, S. J., Greene, W. C., Cossman, J., Hsu, S. M., Jensen, J. P., Neckers, L. M., Marshall, S. L., Bakhshi, A., Depper, J. M., Leonard, W. J., Jaffe, E. S., and Waldmann, T. A. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc. Natl. Acad. Sci. USA, 80: 4522-4526, 1983.
24. Piro, L. D., Carrera, C. J., Son, D. A., and Beutler, E. Lasting remission in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N. Engl. J. Med., 322: 1117-1121, 1990.
25. Saven, A., and Piro, L. D. Newer purine analogue for the treatment of hairy cell leukemia. N. Engl. J. Med., 330: 691-697, 1994.
26. Juliusson, G., Heldal, D., Hippe, E., Hedenus, M., Malm, C., Wallman, K., Stolt, C-M., Evensen, S. A., Albertioni, F., Tjonnfjord, G., Leukei, R., and Liliemark, J. Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia. J. Clin. Oncol., 13: 989-995, 1995.
27. Al-Katib, A., Mohammad, R. M., Khan, K., Dan, M. E., Pettit, G. R., and Sensenbrenner, L. L. Bryostatin 1-induced modulation of the acute lymphoblastic leukemia cell line Reh. J. Immunother., 14: 33-41, 1993.
28. Kawasaki, H., Carrera, C. J., Piro, D. L., Saven, A., Kipps, T. J., and Carson, D. A. Relationship of deoxycytidine kinase and cytoplasmic 5′-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine. Blood, 81: 597-601, 1993.